International Journal of Medical and Health Research


International Journal of Medical and Health Research


International Journal of Medical and Health Research
International Journal of Medical and Health Research
Vol. 5, Issue 6 (2019)

“Treatment and interference of Common Complications of Chronic Kidney disorder: A study in Dhaka Shishu (Children) Hospital, Dhaka, Bangladesh”


Dr. Md Abdur Rouf, AKM Khairul Islam, Dr. Md Atiqul Islam

Chronic Kidney disorder (CKD) could be a worldwide public ill health with associate increasing incidence and prevalence. Outcomes of CKD embrace not solely complications of small excretory organ perform and disorder however additionally nephrosis inflicting hyperbolic morbidity and mortality. Sadly, CKD is commonly undetected and undertreated as a result of its insidious onset, variable progression, and length of time to explicit nephrosis. This study was conduct June 2016 form July 2017 serve Renal & Dialysis Unit Dhaka shishu (Children) Hospital a damage or decreased kidney polygenic disorder is currently the leading reason behind CKD requiring excretory organ replacement medical aid in several elements of the globe, and its prevalence is increasing disproportionately within the developing countries. This literary criticism outlines the present recommendations from numerous clinical pointers and analysis studies for treatment, hindrance and delaying the progression of each CKD and its common complications like vital sign cardiovascular disease, anemia, excretory organ dystrophy, solution and acid base imbalance. Recommendations for nutrition in CKD and measures adopted for early diabetic nephrosis to stop any progression have additionally been reviewed. This study proof that early detection and management of CKD will forestall or cut back illness progression, decrease complications and improve outcomes proof supports that achieving best aldohexose management, blood pressure, reduction in symptom with a complex intervention slows the progression of CKD. Angiotensin-converting catalyst inhibitors and angiotensin-2 receptor antagonists are best as a result of their distinctive ability to decrease symptom, an element necessary for the progression of CKD.
Pages : 81-88 | 498 Views | 105 Downloads